Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Identifying Suspicious Skin Lesions with a Noninvasive, Painless Device

Published: Monday, October 28, 2013
Last Updated: Sunday, October 27, 2013
Bookmark and Share
VivaScope®cellular imaging devices from Caliber Imaging & Diagnostics.

One in five Americans will develop skin cancer. According to a 2007 study in Archives of Dermatology, more than 3.5 million skin cancers are diagnosed annually-more new cases than breast, prostate, lung and colon cancers combined.

One might think that most people wouldn't hesitate to consult a dermatologist or their general practitioner about any bump, mole or discoloration on their body, since many skin cancers can now be successfully treated if found sufficiently early.

It is surprising that anyone with a skin lesion would hesitate before seeking medical evaluation - one excuse people give is that if they ignore it, it will just go away. Why else do people wait? Some may honestly believe their moles are nothing to worry about.

Others are terrified that a biopsy would leave a scar, a concern that does hold some validity since the majority of skin lesions are benign, but until recently, could only be proven benign by performing a biopsy and examining the surgically removed tissue under a microscope.

One innovative company, Caliber Imaging & Diagnostics, led by CEO L. Michael Hone, has taken the steam out of that last excuse with their FDA-cleared VivaScope®cellular imaging devices.

These new tools allow physicians to biopsy and technicians to evaluate a patient's skin, at and below the skin surface, using imaging rather than surgical options.

Says Hone: "The best medicine with regard to skin cancer is prevention. One should always consider sun protection, apply SPF-30 every day and wear a hat and sunglasses outdoors. The second-best medicine is to consult one's health care provider immediately when one spots anything that might be the least bit questionable. And when a doctor is consulted, ask if they have a noninvasive way to biopsy skin. Doctors should want to provide patients with a painless, noninvasive optical skin biopsy in lieu of the traditional biopsy to help them make a diagnosis."

The company is already marketing its VivaScope systems, including two handheld VivaScopes, the 1500 and 3000, and the VivaScope 2500 for use in the operating room. Another advantage: no waiting. Obtaining the image takes only five to 10 minutes.

"Our technology can image down into the entire lesion, layer by layer, and immediately help doctors eliminate or diagnose a variety of skin diseases and disorders," says Hone.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,200+ scientific posters on ePosters
  • More than 4,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Liquid Biopsies: Miracle Diagnostic or Next New Fad?
Thanks to the development of highly specific gene-amplification and sequencing technologies liquid biopsies access more biomarkers relevant to more cancers than ever before.
Drug - Gene 'One-Two' Punch Against Cancer
Researchers identify gene-drug combinations that, together, target and kill cancer cells while not targeting healthy cells.
Liquid Biopsies Treating Ovarian Cancer
Researchers have discovered a promising monitor and treat recurrence of ovarian cancer. Detecting cancer long before tumours reappear.
72% Rise in Metastatic Prostate Cancer
Over the 2003-2013 period metastatic cancer has increased by an average of 72%, this could be caused by lax screening, more aggressive disease or both.
Lab-Tested Diagnosis Needed When Treating Persistent Diarrhea
New PCR multiplex method makes lab testing more effective.
Biomarker for Multiple Sclerosis Detection Discovered
Winthrop-University Hospital researchers discover biomarker for multiple sclerosis detection.
Scientists Link Bipolar Disorder to Unexpected Brain Region
Researchers from The Scripps Research Institute have found that gene within the brain’s striatum could be linked to biopolar disorder.
Liquid Biopsies: DNA Size Matters
Study finds circulating tumour DNA can be distinguished from healthy DNA through fragment size identification.
Accessing Metabolic Information with Mass Spec
Scientists at the Helmholtz Zentrum München have developed a new mass spectrometry imaging method which, for the first time, makes it possible to analyze hundreds of metabolites in fixed tissue samples.
Zika Epidemic Likely to End Within Three Years
A team of scientists has predicted that the current Zika epidemic is likely to end within three years because there will be too few people left to infect.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!